IP Library Patent Application 14127296
Patent Application
App. No. 14/127,296

EFFICIENT INDUCTION OF DEFINITIVE ENDODERM FROM PLURIPOTENT STEM CELLS

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
14/127,296
Abstract

The present invention relates to a method to differentiate pluripotent stem cells to a primitive streak cell population, in a stepwise manner for further maturation to definitive endoderm.

Claims (20)

1 - 15 . (canceled)

16 . A method for differentiation of stem cells into definitive endoderm comprising the steps of:

a. incubating stem cells in a medium comprising at least 2 μM CHIR, wherein activin A is not present; and

b. subsequently incubating stem cells in a medium comprising activin A.

17 . The method according to claim 16 , wherein said medium is RPMI-1640.

18 . The method according to claim 16 , wherein said stem cells are embryonic stem cells or induced pluripotent stem cells.

19 . The method according to claim 16 , wherein the concentration of CHIR is at least about 2.5 μM.

20 . The method according to claim 16 , wherein the concentration of CHIR is at least about 3.1 μM.

21 . The method according to claim 16 , wherein the concentration of CHIR is in a range selected from the group consisting of about 2.5-15 μM, about 3.1-15 μM, about 3.1-7 μM, 3.5-7 μM, about 3.5-6 μM, and about 3.5-5 μM.

22 . The method according to claim 16 , wherein the concentration of CHIR is at least about 3.5 μM.

23 . The method according to claim 16 , wherein said incubation with CHIR is at least 24 hours.

24 . The method according to claim 16 , wherein said incubation with activin A is at least 24 hours.

25 . The method according to claim 16 , wherein said incubation with activin A is 48 to 72 hours.

26 . The method according to claim 16 , wherein endodermal cells are obtained from said definitive endoderm cells.

27 . The method according to claim 26 , wherein said endoderm cells are pancreatic endoderm cells.

28 . Pancreatic endoderm cells obtainable by the method of claim 27 .

29 . The method according to claim 16 , wherein the concentration of CHIR in the culture medium is at least 3 μM.

30 . The method according to claim 16 , wherein the concentration of CHIR in the culture medium is in a range selected from the group consisting of about 2-15 μM, about 3-15 μM, about 3.1-15 μM, about 3.1-7 μM, about 3.5-15 μM, and about 3.5-7 μM.

31 . A method for inducing primitive streak cells from embryonic stem cells by using CHIR in a concentration of at least 2 μM in the culture medium.

32 . A method for inducing definitive endoderm cells from embryonic stem cells by using CHIR in a concentration in the range of 3.5-7 μM.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 1, 2026
From: NOVO NORDISK A/S
To: ASPECT BIOSYSTEMS LTD.
Reel/Frame 075363/0935 →
CHANGE OF NAME Recorded Nov 18, 2015
From: CELLARTIS AB
To: TAKARA BIO EUROPE AB
Reel/Frame 037128/0385 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 7, 2014
From: FUNA, NINA; HESS, KATJA; EKBERG, JENNY; SEMB, HENRIK
To: NOVO NORDISK A/S; CELLARTIS AB
Reel/Frame 032618/0971 →